ID   KC1G2_HUMAN             Reviewed;         415 AA.
AC   P78368; B5BU42; O00704; Q8WUB1;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   12-OCT-2022, entry version 208.
DE   RecName: Full=Casein kinase I isoform gamma-2;
DE            Short=CKI-gamma 2;
DE            EC=2.7.11.1;
GN   Name=CSNK1G2; Synonyms=CK1G2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Testis;
RX   PubMed=9403068; DOI=10.1006/geno.1997.4991;
RA   Kitabayashi A.N., Kusuda J., Hirai M., Hashimoto K.;
RT   "Cloning and chromosomal mapping of human casein kinase I gamma 2
RT   (CSNK1G2).";
RL   Genomics 46:133-137(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H., Maruyama Y.,
RA   Matsuo K., Minami K., Mitsubori M., Mori M., Morishita R., Murase A.,
RA   Nishikawa A., Nishikawa S., Okamoto T., Sakagami N., Sakamoto Y.,
RA   Sasaki Y., Seki T., Sono S., Sugiyama A., Sumiya T., Takayama T.,
RA   Takayama Y., Takeda H., Togashi T., Yahata K., Yamada H., Yanagisawa Y.,
RA   Endo Y., Imamoto F., Kisu Y., Tanaka S., Isogai T., Imai J., Watanabe S.,
RA   Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in vitro-
RT   expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION IN BRAIN DEVELOPMENT.
RX   PubMed=15342122; DOI=10.1016/j.neulet.2004.06.054;
RA   Yinan M., Yu Q., Zhiyue C., Jianjun L., Lie H., Liping Z., Jianhui Z.,
RA   Fang S., Dingfang B., Qing L., Xiru W.;
RT   "Polymorphisms of casein kinase I gamma 2 gene associated with simple
RT   febrile seizures in Chinese Han population.";
RL   Neurosci. Lett. 368:2-6(2004).
RN   [8]
RP   FUNCTION AS MTA1 KINASE, INTERACTION WITH MTA1, SUBCELLULAR LOCATION, AND
RP   ACTIVITY REGULATION.
RX   PubMed=15077195; DOI=10.1038/sj.onc.1207569;
RA   Mishra S.K., Yang Z., Mazumdar A., Talukder A.H., Larose L., Kumar R.;
RT   "Metastatic tumor antigen 1 short form (MTA1s) associates with casein
RT   kinase I-gamma2, an estrogen-responsive kinase.";
RL   Oncogene 23:4422-4429(2004).
RN   [9]
RP   FUNCTION IN PER1 STABILITY.
RX   PubMed=15917222; DOI=10.1074/jbc.m502862200;
RA   Shirogane T., Jin J., Ang X.L., Harper J.W.;
RT   "SCFbeta-TRCP controls clock-dependent transcription via casein kinase 1-
RT   dependent degradation of the mammalian period-1 (Per1) protein.";
RL   J. Biol. Chem. 280:26863-26872(2005).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   FUNCTION AS SMAD3 KINASE, INTERACTION WITH SMAD3, AND PHOSPHORYLATION.
RX   PubMed=18794808; DOI=10.1038/onc.2008.337;
RA   Guo X., Waddell D.S., Wang W., Wang Z., Liberati N.T., Yong S., Liu X.,
RA   Wang X.-F.;
RT   "Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1
RT   gamma 2, an inhibitor of TGF-beta signaling.";
RL   Oncogene 27:7235-7247(2008).
RN   [12]
RP   FUNCTION AS COL4A3BP/CERT KINASE.
RX   PubMed=19005213; DOI=10.1091/mbc.e08-07-0669;
RA   Tomishige N., Kumagai K., Kusuda J., Nishijima M., Hanada K.;
RT   "Casein kinase I{gamma}2 down-regulates trafficking of ceramide in the
RT   synthesis of sphingomyelin.";
RL   Mol. Biol. Cell 20:348-357(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   SUBCELLULAR LOCATION, DOMAIN, AND PHOSPHORYLATION.
RX   PubMed=26481050; DOI=10.1016/j.devcel.2015.09.016;
RA   Bailey M.J., Prehoda K.E.;
RT   "Establishment of Par-Polarized Cortical Domains via Phosphoregulated
RT   Membrane Motifs.";
RL   Dev. Cell 35:199-210(2015).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 43-353 IN COMPLEX WITH
RP   5-IODOTUBERCIDIN.
RA   Bunkoczi G., Rellos P., Das S., Ugochukwu E., Fedorov O., Sobott F.,
RA   Eswaran J., Amos A., Ball L., Von Delft F., Bullock A., Debreczeni J.,
RA   Turnbull A., Sundstrom M., Weigelt J., Arrowsmith C., Edwards A., Knapp S.;
RT   "The structure of casein kinase 1 gamma 2.";
RL   Submitted (JUL-2011) to the PDB data bank.
RN   [18]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-189; GLY-194; THR-196; CYS-206;
RP   HIS-206; SER-207; GLN-208; CYS-217 AND MET-223.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase. Casein kinases are
CC       operationally defined by their preferential utilization of acidic
CC       proteins such as caseins as substrates. It can phosphorylate a large
CC       number of proteins. Participates in Wnt signaling. Phosphorylates
CC       COL4A3BP/CERT, MTA1 and SMAD3. Involved in brain development and
CC       vesicular trafficking and neurotransmitter releasing from small
CC       synaptic vesicles. Regulates fast synaptic transmission mediated by
CC       glutamate. SMAD3 phosphorylation promotes its ligand-dependent
CC       ubiquitination and subsequent proteasome degradation, thus inhibiting
CC       SMAD3-mediated TGF-beta responses. Hyperphosphorylation of the serine-
CC       repeat motif of COL4A3BP/CERT leads to its inactivation by dissociation
CC       from the Golgi complex, thus down-regulating ER-to-Golgi transport of
CC       ceramide and sphingomyelin synthesis. Triggers PER1 proteasomal
CC       degradation probably through phosphorylation.
CC       {ECO:0000269|PubMed:15077195, ECO:0000269|PubMed:15342122,
CC       ECO:0000269|PubMed:15917222, ECO:0000269|PubMed:18794808,
CC       ECO:0000269|PubMed:19005213}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- ACTIVITY REGULATION: Stimulated by estrogen. Repressed by 5-
CC       iodotubercidin (DB04604). {ECO:0000269|PubMed:15077195}.
CC   -!- SUBUNIT: Monomer (By similarity). Interacts with MTA1 (short isoform)
CC       in the cytoplasm. Interacts with SMAD3. {ECO:0000250,
CC       ECO:0000269|PubMed:15077195, ECO:0000269|PubMed:18794808,
CC       ECO:0000269|Ref.17}.
CC   -!- INTERACTION:
CC       P78368; Q92624: APPBP2; NbExp=3; IntAct=EBI-748380, EBI-743771;
CC       P78368; Q9Y5P4: CERT1; NbExp=5; IntAct=EBI-748380, EBI-739994;
CC       P78368; Q9Y5P4-2: CERT1; NbExp=4; IntAct=EBI-748380, EBI-11156432;
CC       P78368; P60409: KRTAP10-7; NbExp=3; IntAct=EBI-748380, EBI-10172290;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cell cortex
CC       {ECO:0000269|PubMed:26481050}. Cytoplasm {ECO:0000269|PubMed:15077195,
CC       ECO:0000269|PubMed:26481050}.
CC   -!- TISSUE SPECIFICITY: Testis.
CC   -!- DOMAIN: The phospho-regulated basic and hydrophobic (PRBH) motif is
CC       sufficient and important for interaction with phospholipids permitting
CC       cortical localization (PubMed:26481050). Phosphorylation of the PRBH
CC       motif by aPKC inhibits the association of the protein with the cortical
CC       membrane (PubMed:26481050). {ECO:0000269|PubMed:26481050}.
CC   -!- PTM: Autophosphorylated (PubMed:18794808). Phosphorylated by aPKC which
CC       promotes dissociation from the cell cortex (PubMed:26481050).
CC       {ECO:0000269|PubMed:18794808, ECO:0000269|PubMed:26481050}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CK1 Ser/Thr
CC       protein kinase family. Casein kinase I subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U89896; AAB88627.1; -; mRNA.
DR   EMBL; BT009922; AAP88924.1; -; mRNA.
DR   EMBL; AF001177; AAC00212.1; -; Transcribed_RNA.
DR   EMBL; AB451278; BAG70092.1; -; mRNA.
DR   EMBL; AB451410; BAG70224.1; -; mRNA.
DR   EMBL; AC005306; AAC26983.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW69430.1; -; Genomic_DNA.
DR   EMBL; BC018693; AAH18693.1; -; mRNA.
DR   EMBL; BC018699; AAH18699.1; -; mRNA.
DR   EMBL; BC020972; AAH20972.1; -; mRNA.
DR   CCDS; CCDS12077.1; -.
DR   RefSeq; NP_001310.3; NM_001319.6.
DR   PDB; 2C47; X-ray; 2.40 A; A/B/C/D=43-353.
DR   PDBsum; 2C47; -.
DR   AlphaFoldDB; P78368; -.
DR   SMR; P78368; -.
DR   BioGRID; 107839; 92.
DR   IntAct; P78368; 61.
DR   MINT; P78368; -.
DR   STRING; 9606.ENSP00000255641; -.
DR   BindingDB; P78368; -.
DR   ChEMBL; CHEMBL2543; -.
DR   DrugBank; DB04604; 5-iodotubercidin.
DR   DrugBank; DB03083; IC261.
DR   DrugBank; DB03693; N-(2-Aminoethyl)-5-Chloroisoquinoline-8-Sulfonamide.
DR   DrugCentral; P78368; -.
DR   GuidetoPHARMACOLOGY; 2000; -.
DR   iPTMnet; P78368; -.
DR   PhosphoSitePlus; P78368; -.
DR   SwissPalm; P78368; -.
DR   BioMuta; CSNK1G2; -.
DR   DMDM; 3024060; -.
DR   EPD; P78368; -.
DR   jPOST; P78368; -.
DR   MassIVE; P78368; -.
DR   MaxQB; P78368; -.
DR   PaxDb; P78368; -.
DR   PeptideAtlas; P78368; -.
DR   PRIDE; P78368; -.
DR   ProteomicsDB; 57596; -.
DR   Antibodypedia; 22865; 487 antibodies from 30 providers.
DR   DNASU; 1455; -.
DR   Ensembl; ENST00000255641.13; ENSP00000255641.7; ENSG00000133275.16.
DR   GeneID; 1455; -.
DR   KEGG; hsa:1455; -.
DR   MANE-Select; ENST00000255641.13; ENSP00000255641.7; NM_001319.7; NP_001310.3.
DR   UCSC; uc002lul.5; human.
DR   CTD; 1455; -.
DR   DisGeNET; 1455; -.
DR   GeneCards; CSNK1G2; -.
DR   HGNC; HGNC:2455; CSNK1G2.
DR   HPA; ENSG00000133275; Low tissue specificity.
DR   MIM; 602214; gene.
DR   neXtProt; NX_P78368; -.
DR   OpenTargets; ENSG00000133275; -.
DR   PharmGKB; PA26955; -.
DR   VEuPathDB; HostDB:ENSG00000133275; -.
DR   eggNOG; KOG1165; Eukaryota.
DR   GeneTree; ENSGT00940000156470; -.
DR   InParanoid; P78368; -.
DR   OMA; HANMIHI; -.
DR   PhylomeDB; P78368; -.
DR   TreeFam; TF313349; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   PathwayCommons; P78368; -.
DR   Reactome; R-HSA-1660661; Sphingolipid de novo biosynthesis.
DR   Reactome; R-HSA-4641262; Disassembly of the destruction complex and recruitment of AXIN to the membrane.
DR   SignaLink; P78368; -.
DR   SIGNOR; P78368; -.
DR   BioGRID-ORCS; 1455; 15 hits in 1115 CRISPR screens.
DR   ChiTaRS; CSNK1G2; human.
DR   EvolutionaryTrace; P78368; -.
DR   GenomeRNAi; 1455; -.
DR   Pharos; P78368; Tchem.
DR   PRO; PR:P78368; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; P78368; protein.
DR   Bgee; ENSG00000133275; Expressed in left testis and 200 other tissues.
DR   ExpressionAtlas; P78368; baseline and differential.
DR   Genevisible; P78368; HS.
DR   GO; GO:0005938; C:cell cortex; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0006897; P:endocytosis; IBA:GO_Central.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IBA:GO_Central.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR022247; Casein_kinase-1_gamma_C.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF12605; CK1gamma_C; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cytoplasm; Kinase; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase; Wnt signaling pathway.
FT   CHAIN           1..415
FT                   /note="Casein kinase I isoform gamma-2"
FT                   /id="PRO_0000192842"
FT   DOMAIN          46..316
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..36
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          340..383
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          369..415
FT                   /note="Phospho-regulated basic and hydrophobic (PRBH)
FT                   motif"
FT                   /evidence="ECO:0000269|PubMed:26481050"
FT   COMPBIAS        1..21
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        341..375
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        165
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         52..60
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         75
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   VARIANT         189
FT                   /note="F -> L (in dbSNP:rs55702630)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042086"
FT   VARIANT         194
FT                   /note="E -> G (in dbSNP:rs55780547)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042087"
FT   VARIANT         196
FT                   /note="I -> T (in dbSNP:rs55923222)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042088"
FT   VARIANT         206
FT                   /note="Y -> C (in dbSNP:rs56264133)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042089"
FT   VARIANT         206
FT                   /note="Y -> H (in dbSNP:rs56108438)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042090"
FT   VARIANT         207
FT                   /note="R -> S (in dbSNP:rs56340103)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042091"
FT   VARIANT         208
FT                   /note="E -> Q (in dbSNP:rs55818316)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042092"
FT   VARIANT         217
FT                   /note="R -> C (in dbSNP:rs55754218)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042093"
FT   VARIANT         223
FT                   /note="T -> M (in dbSNP:rs56038081)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042094"
FT   CONFLICT        113
FT                   /note="K -> N (in Ref. 2; AAP88924 and 6; AAH20972)"
FT                   /evidence="ECO:0000305"
FT   STRAND          46..51
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   STRAND          60..65
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   TURN            66..68
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   STRAND          71..78
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   HELIX           86..95
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   TURN            96..98
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   STRAND          105..111
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   STRAND          114..120
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   HELIX           126..132
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   TURN            133..135
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   HELIX           139..158
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   HELIX           168..170
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   STRAND          171..173
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   TURN            179..182
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   STRAND          183..186
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   STRAND          193..196
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   TURN            198..200
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   TURN            216..218
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   HELIX           221..224
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   HELIX           231..247
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   TURN            251..254
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   STRAND          257..259
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   HELIX           260..272
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   HELIX           276..279
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   TURN            280..282
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   HELIX           285..295
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   HELIX           305..318
FT                   /evidence="ECO:0007829|PDB:2C47"
FT   TURN            328..331
FT                   /evidence="ECO:0007829|PDB:2C47"
SQ   SEQUENCE   415 AA;  47457 MW;  036A39148A1DA038 CRC64;
     MDFDKKGGKG ETEEGRRMSK AGGGRSSHGI RSSGTSSGVL MVGPNFRVGK KIGCGNFGEL
     RLGKNLYTNE YVAIKLEPIK SRAPQLHLEY RFYKQLSATE GVPQVYYFGP CGKYNAMVLE
     LLGPSLEDLF DLCDRTFTLK TVLMIAIQLI TRMEYVHTKS LIYRDVKPEN FLVGRPGTKR
     QHAIHIIDFG LAKEYIDPET KKHIPYREHK SLTGTARYMS INTHLGKEQS RRDDLEALGH
     MFMYFLRGSL PWQGLKADTL KERYQKIGDT KRATPIEVLC ENFPEEMATY LRYVRRLDFF
     EKPDYDYLRK LFTDLFDRSG FVFDYEYDWA GKPLPTPIGT VHTDLPSQPQ LRDKTQPHSK
     NQALNSTNGE LNADDPTAGH SNAPITAPAE VEVADETKCC CFFKRRKRKS LQRHK
//
